The prognostic value of tumor–stroma ratio in tumor‐positive axillary lymph nodes of breast cancer patients
- 16 October 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 143 (12) , 3194-3200
Abstract
The tumor–stroma ratio (TSR) has previously been found to be a strong prognostic parameter in primary breast cancer tumors. Since the presence of tumor cells in lymph nodes is important for clinical decision making, the influence of TSR in the primary breast tumor combined with the TSR in tumor‐positive lymph nodes on prognosis was evaluated. Women with invasive breast cancer without distant metastasis who underwent an axillary lymph node dissection between 1985 and 1994 at the Leiden University Medical Center were retrospectively analyzed. TSR assessment was performed on hematoxylin and eosin stained tissue slides. In total, 87 (45.5%) primary tumors were scored as stroma‐low and 104 (54.5%) as stroma‐high. Patients with a high stromal percentage in the primary tumors had a statistically significant worse relapse free period (RFP) compared to stroma‐low tumors (HR 1.97, 95% CI 1.37–2.82, p < 0.001). A total number of 915 lymph nodes were assessed for TSR. In 101 (52.9%) patients, heterogeneity was observed between stroma percentage category in primary tumor and lymph nodes. The combination of TSR of the primary tumor combined with TSR of tumor‐positive lymph nodes strengthened each other as independent prognostic parameter for RFP (p = 0.019). Patients with primary tumor stroma‐low/lymph nodes stroma‐low tumors showed strongly improved RFP rates compared to patients with primary tumor stroma‐high/lymph node stroma‐high tumors with 10‐year percentages of 58 versus 8%, respectively. Assessing the TSR on tumor‐positive lymph nodes can provide additional prognostic information. Stromal activation strongly differs between primary tumors and lymph node metastasis.Keywords
Funding Information
- Keukenhof voor de Vroege Opsporing van Kanker, Lisse
This publication has 16 references indexed in Scilit:
- The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancerBritish Journal of Cancer, 2014
- The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancerAnnals of Oncology, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell CarcinomaJournal of Thoracic Oncology, 2012
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trialAnnals of Oncology, 2012
- The prognostic value of tumour-stroma ratio in triple-negative breast cancerEuropean Journal of Surgical Oncology, 2012
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsBritish Journal of Cancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- Fibroblasts in cancerNature Reviews Cancer, 2006